Condensed Statements of Cash Flows - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (10,656)	$ 456,861
Adjustments to reconcile net income (loss) to net cash used in operating activities
Realized and unrealized gains on investments held in the Trust Account	0	(1,284,814)
Changes in operating assets and liabilities:
Prepaid expenses	0	150,659
Accrued offering costs	0	(349,109)
Accrued expenses	1,000	52,914
Net cash used in operating activities	(9,656)	(973,489)
Cash flows from financing activities:
Deferred offering costs	(87,134)	0
Proceeds from related party	0	4,734
Proceeds from convertible note – related party	96,840	300,000
Net cash provided by financing activities	9,656	304,734
Net change in cash	0	(668,755)
Cash at beginning of period	0	935,802
Cash at end of period	0	267,047
Non-cash financing activities:
Deferred offering costs included in accrued offering costs	125,196	0
Deferred offering costs paid in exchange for ordinary shares	25,000	0
Remeasurement of Class A ordinary shares to redemption value	$ 0	$ 1,296,150